Colorado lawmakers just hit pause on a high-profile effort to keep closer tabs on hospital mergers, even as new national data show a small number of systems already dominate the state’s hospital market. Senate Bill 41, sponsored by Democratic Sens. Cathy Kipp and Mike Weissman, would have given the Colorado attorney general more power to review and potentially block hospital deals. Instead, the Senate Health & Human Services Committee voted last Thursday to postpone the bill indefinitely, shelving the proposal and giving hospital opponents of the measure a clear, if possibly temporary, victory.
New data shows local markets are tightly consolidated
At almost the same time, fresh research from the Health Care Affordability Lab at Yale put hard numbers to what patients and providers have been feeling for years. The lab’s new hospital-markets visualization finds that roughly two-thirds of Colorado’s roughly 80 hospitals are either under highly concentrated ownership or effectively operate as monopolies in their local markets. Local stories and national roundups have since highlighted Colorado in broader maps of hospital consolidation across the Mountain West.
What SB 41 would have changed
Supporters framed SB 41 as a straightforward check on that consolidation. The bill would have expanded the circumstances in which the Colorado attorney general could investigate and block transactions involving hospitals, required at least 60 days’ notice for certain “material change” deals, and allowed the AG to charge a filing fee of up to $5,000, as laid out on the Colorado General Assembly website. It also would have barred parties from closing a transaction that “may substantially lessen competition” until the AG finished a review, and it could have brought filing materials under state public-records rules.
Why the bill stalled
During the committee hearing, Kipp described SB 41 as a consumer-protection tool and told colleagues it was “not a radical ask” given rising health care prices. But opponents, joined by several committee Democrats, warned that the proposal might slow or derail deals that struggling hospitals see as lifelines, especially in rural communities.
Sen. Kyle Mullica, an emergency-room nurse who voted to postpone the bill, said many rural providers had a blunt message for legislators: the bill was “not about consolidation - it’s about survival,” according to The Sum and Substance. Hospital leaders have also stressed their financial strain, pointing to Colorado Hospital Association data that nearly 70% of hospitals in the state ended 2024 with margins the group labeled unsustainable. They argue that tighter oversight would be tough to square with that balance-sheet reality.
Consolidation and the price tag
Health policy experts have long warned that concentrated hospital markets tend to push prices higher. An analysis from KFF found that hospital care alone accounted for 40% of the growth in national health spending between 2022 and 2024, a far larger share than any other category. National reporting has also tracked a long merger wave, tallying roughly 1,300 hospital transactions since 2000, with federal regulators stepping in to challenge only a subset of those deals. Advocates for stricter state oversight frequently point to that track record when they argue that Washington intervention by itself is not enough.
What’s next in Colorado
This is not the first time Colorado lawmakers have floated stronger oversight of hospital deals, and supporters say it almost certainly will not be the last. They expect the Yale lab’s state-by-state rankings to become a recurring exhibit in future debates over market power and prices.
In the meantime, Colorado continues to lean on existing transparency tools. The state already publishes hospital data and performance reports through the Department of Health Care Policy & Financing, which officials cite as a way to track prices, margins and access while policymakers weigh next steps. Those datasets are available through the agency’s Department of Health Care Policy & Financing hospital reports hub.
Legal implications
If lawmakers revive SB 41 or a similar measure, its provisions expanding the attorney general’s review authority could raise questions about how new state scrutiny would interact with existing federal antitrust filings and Hart-Scott-Rodino notification thresholds, as described in the bill text and fiscal note. The complete bill language and the committee report remain available on the Colorado General Assembly site for those tracking the potential legal tradeoffs.
